Literature DB >> 30415130

Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.

Hongru Li1, Benjamin K Chen2.   

Abstract

HIV-1 transmission is usually initiated by a single viral strain called transmitted/ founder (T/F) virus. In in vitro models, HIV-1 can efficiently spread via cell-free and virological synapse (VS)-mediated cell-to-cell infection. Both modes of infection require the viral glycoprotein Envelope (Env). The efficiency with which T/F Envs initiate VS and mediate cell-to-cell infection has not been well characterized. Here we tested a panel of isogenic HIV-1 molecular clones that carry different Clade B T/F Envs. We found that despite variable infectivity among different Env clones in the two modes of infection, T/F Envs generally mediated efficient VS formation and subsequent cell-to-cell transfer. In contrast, in vitro infectivity of the T/F Env clones was more variable and strongly correlated with intrinsic fusogenicity of various Envs. We speculate that the conservation of cell-to-cell transfer by T/F Env is indicative of a biologically important function of Env.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell-free infection; Cell-to-cell infection; Cell-to-cell transfer; Envelope (Env); Fusogenicity; Human immunodeficiency virus type 1 (HIV-1); Transmitted/ founder (T/F); Virological synapses (VS)

Mesh:

Substances:

Year:  2018        PMID: 30415130      PMCID: PMC6322399          DOI: 10.1016/j.virol.2018.10.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  76 in total

1.  Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

Authors:  Cynthia A Derdeyn; Julie M Decker; Frederic Bibollet-Ruche; John L Mokili; Mark Muldoon; Scott A Denham; Marintha L Heil; Francis Kasolo; Rosemary Musonda; Beatrice H Hahn; George M Shaw; Bette T Korber; Susan Allen; Eric Hunter
Journal:  Science       Date:  2004-03-26       Impact factor: 47.728

Review 2.  Retrovirus envelope glycoproteins.

Authors:  E Hunter; R Swanstrom
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.

Authors:  Rebecca M Lynch; Rong Rong; Saikat Boliar; Anurag Sethi; Bing Li; Joseph Mulenga; Susan Allen; James E Robinson; S Gnanakaran; Cynthia A Derdeyn
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

4.  Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses.

Authors:  Yi Liu; Marcel E Curlin; Kurt Diem; Hong Zhao; Ananta K Ghosh; Haiying Zhu; Amanda S Woodward; Janine Maenza; Claire E Stevens; Joanne Stekler; Ann C Collier; Indira Genowati; Wenjie Deng; Rafael Zioni; Lawrence Corey; Tuofu Zhu; James I Mullins
Journal:  Virology       Date:  2008-03-07       Impact factor: 3.616

5.  Virus population homogenization following acute human immunodeficiency virus type 1 infection.

Authors:  Gerald H Learn; David Muthui; Scott J Brodie; Tuofu Zhu; Kurt Diem; James I Mullins; Lawrence Corey
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.

Authors:  Randi B Gombos; Dror Kolodkin-Gal; Leila Eslamizar; Joshua O Owuor; Emanuele Mazzola; Ana M Gonzalez; Birgit Korioth-Schmitz; Rebecca S Gelman; David C Montefiori; Barton F Haynes; Joern E Schmitz
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 7.  T cell virological synapses and HIV-1 pathogenesis.

Authors:  Benjamin K Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

8.  Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions.

Authors:  James B Munro; Jason Gorman; Xiaochu Ma; Zhou Zhou; James Arthos; Dennis R Burton; Wayne C Koff; Joel R Courter; Amos B Smith; Peter D Kwong; Scott C Blanchard; Walther Mothes
Journal:  Science       Date:  2014-10-08       Impact factor: 47.728

9.  Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.

Authors:  Markus Koch; Marie Pancera; Peter D Kwong; Peter Kolchinsky; Christoph Grundner; Liping Wang; Wayne A Hendrickson; Joseph Sodroski; Richard Wyatt
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

10.  Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.

Authors:  Kelechi Chikere; Nicholas E Webb; Tom Chou; Katharina Borm; Jasminka Sterjovski; Paul R Gorry; Benhur Lee
Journal:  Retrovirology       Date:  2014-06-23       Impact factor: 4.602

View more
  4 in total

1.  A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants.

Authors:  Allison S Thomas; Melissa Ghulam-Smith; Alex Olson; Carolyn Coote; Oscar Gonzales; Manish Sagar
Journal:  J Immunol Methods       Date:  2020-03-02       Impact factor: 2.287

2.  Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform.

Authors:  Eytan Herzig; Kaman Chan Kim; Thomas A Packard; Noam Vardi; Roland Schwarzer; Andrea Gramatica; Steven G Deeks; Steven R Williams; Kyle Landgraf; Nigel Killeen; David W Martin; Leor S Weinberger; Warner C Greene
Journal:  Cell       Date:  2019-10-24       Impact factor: 41.582

3.  In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha.

Authors:  Manickam Ashokkumar; Aanand Sonawane; Maike Sperk; Srikanth P Tripathy; Ujjwal Neogi; Luke Elizabeth Hanna
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

4.  Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts.

Authors:  Larisa Dubrovsky; Adam Ward; Soo-Ho Choi; Tatiana Pushkarsky; Beda Brichacek; Christophe Vanpouille; Alexei A Adzhubei; Nigora Mukhamedova; Dmitri Sviridov; Leonid Margolis; Richard B Jones; Yury I Miller; Michael Bukrinsky
Journal:  mBio       Date:  2020-01-21       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.